Skip to main content
. 2023 Jul 26;62(8):1063–1079. doi: 10.1007/s40262-023-01284-w

Fig. 7.

Fig. 7

Log-linear plots of mean (± standard deviation [SD]) plasma brigatinib concentration–time profiles with and without coadministration of a the strong cytochrome P450 (CYP) 2C8 inhibitor gemfibrozil, b the strong CYP3A inhibitor itraconazole, and c the strong CYP3A inducer rifampin [31]. Adapted from Tugnait et al. [31]